Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer

Published:2017-11 Issue: Volume:140 Page:252-273
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Luo Guoshun,Li Xinyu,Zhang Guoqing,Wu Chengzhe,Tang Zhengpu,Liu Linyi,You Qidong,Xiang Hua

Funder

Natural Science Foundation of China

Ministry of National Science and Technology

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference69 articles.

1. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis;Forouzanfar;Lancet,2011

2. Synthesis of targeted dibenzo[b,f]thiepines and dibenzo[b,f]oxepines as potential lead molecules with promising anti-breast cancer activity;Mohd;Eur. J. Med. Chem.,2015

3. Antiestrogens: structure-activity relationships and use in breast cancer treatment;Traboulsi;J. Mol. Endocrinol.,2017

4. Sustained proliferation in cancer: mechanisms and novel therapeutic targets;Feitelson;Seminars Cancer Biol.,2015

5. Assessing women at high risk of breast cancer: a review of risk assessment models;Amir;J. Natl. Cancer Inst.,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships;Biomedicines;2024-05-27

2. 3,3’-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration;PLOS ONE;2024-05-22

3. Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer;European Journal of Medicinal Chemistry;2024-04

4. Extensive Computational Studies for the Identification of Potential Therapeutic Candidates Against Breast Cancer;Current Indian Science;2024-03-19

5. Anticancer mechanism of coumarin-based derivatives;European Journal of Medicinal Chemistry;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3